- Home
- GOSS vs SWZ Comparison
GOSS vs SWZ Comparison
Compare GOSS & SWZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOSS | SWZ |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 77.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOSS | SWZ |
|---|---|---|
| Price | $0.17 | $5.92 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.19 | N/A |
| AVG Volume (30 Days) | ★ 15.1M | 82.5K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.59% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.14 | $5.84 |
| 52 Week High | $3.87 | $6.43 |
Technical Indicators
Market Signals| Indicator | GOSS | SWZ |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 43.85 |
| Support Level | $0.16 | $5.91 |
| Resistance Level | $0.36 | $6.08 |
| Average True Range (ATR) | 0.02 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 47.73 | 40.06 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. It actively manages investment solutions spanning public and private markets, wealth management, and Solutions.